SOLIQS provides Solid Solutions for Insoluble Substances®

SOLIQS, the global drug delivery business of AbbVie Deutschland GmbH & Co. KG provides their formulation expertise to the customers compound. We are focusing on increasing the bioavailability by increasing the solubility of low soluble compounds as well developing specifically designed release profiles.

In providing these patented solutions to the compounds, the various SOLIQS technologies can extend a wide variety of benefits to the patient and our partner's bottom line.

Contact us by e-mail welcome@soliqs.com.

Call us at +49-621-589-2277 International to talk to us about your questions or formulation issue.